VALSCOPE
日本米国
codese.net

Elevance Health, Inc.

ELVUS
SEC EDGARで開く
売上高
$199.1B
百万USD
営業利益
$7.2B
百万USD
純利益
$5.7B
百万USD
ROE
12.9%
最新FY
EPS
$25.21
USD / 株
配当
-
USD / 株

業績推移

収益性

キャッシュフロー

財務状況

四半期業績

年度売上高純利益EPS
FY2021Q1$32.4B$1.7B$6.71
FY2021Q2$33.9B$1.8B$7.25
FY2021Q3$35.8B$1.5B$6.13
FY2021FY$138.6B$6.1B$24.73
FY2022Q1$38.1B$1.8B$7.39
FY2022Q2$38.6B$1.7B$6.79
FY2022Q3$39.9B$1.6B$6.68
FY2022FY$156.6B$6.0B$24.81
FY2023Q1$42.2B$2.0B$8.30
FY2023Q2$43.7B$1.9B$7.79
FY2023Q3$42.8B$1.3B$5.45
FY2023FY$171.3B$6.0B$25.22
FY2024Q1$42.6B$2.2B$9.59
FY2024Q2$43.9B$2.3B$9.85
FY2024Q3$45.1B$1.0B$4.36
FY2024FY$177.0B$6.0B$25.68
FY2025Q1$48.9B$2.2B$9.61
FY2025Q2$49.8B$1.7B$7.72
FY2025Q3$50.7B$1.2B$5.32
FY2025FY$199.1B$5.7B$25.21
FY2026Q1$50.2B$1.8B$8.00

財務データ

指標FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
売上高$84.9B$90.0B$92.1B$104.2B$121.9B$138.6B$156.6B$171.3B$177.0B$199.1B
営業利益$4.8B$4.2B$5.4B$6.0B$6.4B$7.5B$8.5B$8.5B$7.9B$7.2B
純利益$2.5B$3.8B$3.8B$4.8B$4.6B$6.1B$6.0B$6.0B$6.0B$5.7B
総資産$65.1B$70.5B$71.6B$77.5B$86.6B$97.5B$102.8B$108.9B$116.9B$121.5B
純資産-----$36.1B$36.4B$39.4B$41.4B$44.0B
自己資本$25.1B$26.5B$28.5B$31.7B$33.2B$36.1B$36.3B$39.3B$41.3B$43.9B
営業CF$3.2B$4.2B$3.8B$6.1B$10.7B$8.4B$8.4B$8.1B$5.8B$4.3B
EPS$9.21$14.35$14.19$18.47$17.98$24.73$24.81$25.22$25.68$25.21
BPS$94.94$103.64$111.05$125.74$135.56$149.44$152.90$168.94$181.72$198.83
ROE9.8%14.5%13.1%15.2%13.8%16.9%16.6%15.2%14.5%12.9%